1例肝硬化合并胸腔积液患者的抗感染治疗及药学监护  

Anti-infection treatment and pharmaceutical care for one patient of liver cirrhosis complicated with pleural effusion

作　　者：曹喜红[1] 薛培丽[2] 张丽丽[2] 

机构地区：[1]四川省科学城医院药剂科,四川绵阳621900 [2]四川省科学城医院呼吸内科,四川绵阳621900

出　　处：《药学实践杂志》2014年第6期462-464,共3页Journal of Pharmaceutical Practice

摘　　要：目的临床药师通过参与临床药物治疗,对患者进行药学监护,探讨临床药师在临床治疗中的价值。方法结合1例肝硬化合并胸腔积液患者,参与治疗方案的制订,对患者进行用药教育,跟踪疗效及不良反应。结果临床药师参与临床用药,实施药学监护,可以提高药物治疗效果,减少药物不良反应的发生。结论临床药师的参与,可使临床用药更加规范合理,具有一定的参考价值。Objective To investigate the value of clinical pharmacists in clinical treatment through the practice of clinical pharmacists participating in clinical drug treatment and providing pharmaceutical care to patients .Methods Clinical pharmacists were involved in therapeutic scheme making , medication education and drug effect and adverse reaction tracking of one patient of liver cir -rhosis complicated with pleural effusion .Results The effects of drug treatment were improved and the adverse drug reactions were re -duced after the participation of pharmacist in clinical treatment and the implementation of pharmaceutical care for the patient .Conclu-sion The participation of pharmacist in clinical drug therapy could enhance normative and reasonable usage of drugs .This participa-tion is decisive and valuable in clinical treatment .

关 键 词：肝硬化 胸腔积液 药学实践 

分 类 号：R969.3[医药卫生—药理学]